CF Industries (CF) is a Great Momentum Stock: Should You Buy?

Does CF Industries (CF) have what it takes to be a top stock pick for momentum investors? Let's find out.

Zacks Investment Research • a day ago

Bull of the Day: CF Industries (CF)

As a global fertilizer shortage looms and the Strait of Hormuz faces an unprecedented blockade, one North American giant is stepping in to fill the void.

Zacks Investment Research • May 15, 2026

Volatility to Turn Higher as Inflation Resurfaces: Stocks to Watch

Inflation is the biggest risk in this environment amid the Strait of Hormuz blockade, which continues to pressure global energy prices.

Zacks Investment Research • May 14, 2026

Can CF (CF) Run Higher on Rising Earnings Estimates?

CF Industries (CF) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.

Zacks Investment Research • May 13, 2026

CF Industries Holdings, Inc. (CF) Presents at 21st Annual Global Farm to Market Conference Transcript

CF Industries Holdings, Inc. (CF) Presents at 21st Annual Global Farm to Market Conference Transcript

Seeking Alpha • May 13, 2026

20 stocks in the S&P 500 of companies with soaring sales and improving profit margins

This earnings season's big winners include makers of AI-oriented hardware, but the list also includes some surprises.

Market Watch • May 13, 2026

Here's Why CF Industries (CF) is a Strong Momentum Stock

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Zacks Investment Research • May 12, 2026

CF Industries Q1 Earnings Call Highlights

CF Industries NYSE: CF reported first-quarter 2026 adjusted EBITDA of $983 million, as executives said strong operations and a tightening global nitrogen market supported results heading into the North American spring application season.

MarketBeat • May 9, 2026

VRTX's Alyftrek, Journavx & Casgevy See Strong Momentum in Q1 Earnings

Vertex's new drugs are gaining momentum as Alyftrek tops $1 billion in sales and Journavx prescriptions accelerate.

Zacks Investment Research • May 8, 2026

CF Industries Holdings, Inc. (CF) Q1 2026 Earnings Call Transcript

CF Industries Holdings, Inc. (CF) Q1 2026 Earnings Call Transcript

Seeking Alpha • May 7, 2026